C16 Ceramide (d18:1/16:0)
Shipping is calculated in checkout
24696-26-2
≥98%
A crystalline solid
537.9
n-[(1s,2r,3e)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-hexadecanamide, cer(d18:1/16:0), ceramide (d18:1/16:0), n-hexadecanoyl-d-erythro-sphingosine, n-palmitoyl-d-erythro-sphingosine, palmitoyl ceramide
- Data sheet: View or download
- MSDS: View or download
A sphingolipid; levels are increased by PPMP or MAPP in isolated human neutrophils and are correlated with an increase in apoptosis; accumulates in the lungs of patients with cystic fibrosis compared with the lungs of patients with pulmonary hypertension; plasma levels are increased in patients with acute coronary syndrome, and an increased plasma ratio of C16 to C24:0 ceramide is associated with major adverse cardiac events; levels are increased in tumor tissue from patients with breast cancer and is associated with metastatic cancer
-20°C
